301526 国际复材
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入6,413,30619.01%7,361,8077,156,3287,894,2318,300,480
减:营业总成本5,998,9857.39%7,650,6166,720,5766,611,1246,986,815
    其中:营业成本5,279,76914.92%6,436,1045,611,5385,660,2685,722,533
               财务费用86,954-64.14%323,950275,34893,506448,227
               资产减值损失(12,683)-47.69%(171,509)(85,608)(31,199)(15,055)
公允价值变动收益(270)-95.48%(1,689)5,9781,2122,679
投资收益(9,310)-69.18%(60,159)86,48189,31668,606
    其中:对联营企业和合营企业的投资收益(1,522)-92.45%(61,246)37,64233,22463,622
营业利润421,290-417.80%(376,938)624,3251,484,7741,413,974
利润总额404,641-393.84%(379,043)623,6681,453,9041,363,261
减:所得税费用67,792236.32%(4,946)31,571201,464135,375
净利润336,849-313.38%(374,097)592,0971,252,4401,227,886
减:非控股权益63,932-10,954.58%(20,182)46,592108,116130,398
股东净利润272,917-273.53%(353,915)545,5051,144,3241,097,488

市场价值指针
每股收益 (元) *0.070-275.00%-0.0900.1800.3700.360
每股派息 (元) *------0.0300.0440.032
每股净资产 (元) *2.1780.28%2.1102.2672.0801.730
审计意见 #--标准的无保留意见标准的无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容